Latamoxef

Latamoxef

File:Moxalactam synthesis.svg

Synthesis of Moxalactam

Latamoxef, also known as moxalactam, is a beta-lactam antibiotic belonging to the oxacephem class. It is used in the treatment of various bacterial infections and is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria.

Mechanism of Action

Latamoxef works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which are essential for the cross-linking of the peptidoglycan layer. This inhibition leads to the weakening of the cell wall and ultimately causes bacterial cell lysis and death.

Clinical Uses

Latamoxef is used to treat a variety of infections, including:

• Urinary tract infections
• Respiratory tract infections
• Intra-abdominal infections
• Skin and soft tissue infections

It is particularly useful in treating infections caused by Enterobacteriaceae and other resistant organisms.

Side Effects

Common side effects of latamoxef include:

• Gastrointestinal disturbances such as nausea and diarrhea
• Allergic reactions, including rash and anaphylaxis
• Hematological effects such as thrombocytopenia and neutropenia

Synthesis

The synthesis of moxalactam involves the chemical modification of the beta-lactam core to include an oxacephem ring structure. This modification enhances its stability against beta-lactamases and broadens its antibacterial spectrum.

Related Pages

• Beta-lactam antibiotics
• Antibiotic resistance
• Penicillin-binding proteins